Showing results (11-20 of 302) with videos related to
Sort By:
Pageof 31
Scientifica|June 27, 2014
Paediatric inflammatory bowel disease: a mechanistic approach to investigate exclusive enteral nutrition treatmentLily Nahidi, Andrew S Day, Daniel A Lemberg, et al.Digestive Diseases and Sciences|September 3, 2025
The Interplay Between Immunological Status and Gut Microbial Dysbiosis in the Development of the Symptoms of Irritable Bowel Syndrome: A Systematic Review with Meta-AnalysisTasnia Ahmed, Daniel A Lemberg, Andrew S Day, et al.Journal of Paediatrics and Child Health|June 11, 2011
Complementary and alternative medicine in children attending gastroenterology clinics: usage patterns and reasons for useVeena Wadhera, Daniel A Lemberg, Steven T Leach, et al.Journal of Gastroenterology|September 29, 2011
Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro modelLily Nahidi, Andrew S Day, Daniel A Lemberg, et al.Frontiers in Pediatrics|June 10, 2014
The pathophysiology of eosinophilic esophagitisMayumi Raheem, Steven T Leach, Andrew S Day, et al.Digestive Diseases and Sciences|October 16, 2009
C-reactive protein and disease activity in children with Crohn's diseaseSamantha Tilakaratne, Daniel A Lemberg, Steven T Leach, et al.World Journal of Gastroenterology|November 10, 2012
Crohn's and colitis in children and adolescentsAndrew S Day, Oren Ledder, Steven T Leach, et al.Journal of Gastroenterology and Hepatology|February 14, 2009
Defensins and inflammation: the role of defensins in inflammatory bowel diseaseMalith Ramasundara, Steven T Leach, Daniel A Lemberg, et al.Digestive Diseases and Sciences|September 20, 2013
Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activationLily Nahidi, Steven T Leach, Daniel A Lemberg, et al.Frontiers in Pediatrics|February 7, 2018
The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel DiseasesBianca J Galgut, Daniel A Lemberg, Andrew S Day, et al.Pageof 31